CRISPRing the Human Genome for Functional Regulatory Elements


On Friday, 9 March, Rui Lopes from the Oncogenomics group led by Reuven Agami, defended his PhD thesis. He pioneered the application of CRISPR-Cas9 to test the function of enhancers. His experiments identified a number of enhancers that are absolutely required for the growth of cancer cells.

This site uses cookies

This website uses cookies to ensure you get the best experience on our website.